Upregulation of peroxiredoxin III in doxorubicin-induced cytotoxicity and the FoxO3a-dependent expression in H9c2 cardiac cells

Doxorubicin (DOX) is an efficient drug used in cancer therapy; however, it produces reactive oxygen species (ROS) that induce severe cytotoxicity, limiting its clinical application. The aim of the present study was to investigate the role of peroxiredoxin III (Prx III) in DOX-induced H9c2 cell injur...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Exp Ther Med
Huvudupphovsmän: LIU, MI-HUA, ZHANG, YUAN, HE, JUN, TAN, TIAN-PING, WU, SHAO-JIAN, FU, HONG-YUN, CHEN, YU-DAN, LIU, JUN, LE, QUN-FANG, HU, HENG-JING, YUAN, CONG, LIN, XIAO-LONG
Materialtyp: Artigo
Språk:Inglês
Publicerad: D.A. Spandidos 2015
Ämnen:
Articles
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4578044/
https://ncbi.nlm.nih.gov/pubmed/26622517
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/etm.2015.2693
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk